Stephanie Schaub, MD

Locations of Practice

Overview

Dr. Schaub is an Assistant Professor of Radiation Oncology at University of Washington who cares for patients with sarcomas and pediatric patients with all types of tumors. She has expertise in advanced radiation modalities, including proton therapy, intraoperative radiation therapy (IORT), neutron therapy, and stereotactic body radiation therapy (SBRT). Dr. Schaub practices at care at UW Medical Center, Fred Hutchinson Cancer Center – South Lake Union, Seattle Children’s, and the Fred Hutchinson Cancer Center – Proton Therapy.

Patient Care Philosophy

“The treatment of cancer is often not black and white and there can be many different treatment pathways. It is my privilege to work with you and your support system to find the perfect path that aligns with your values, goals, and challenges– taking into consideration the concerns of today, but also accounting for the worries of tomorrow, next year, and the decades beyond. I want you to feel empowered with our shared decisions and I strive to explain the “why” behind our recommendations.”

Education and Training

College: University of California, Davis, CA, 2009

Medical Education:  Florida Atlantic University, Boca Raton, FL, 2015

Internship: Internal Medicine at Harvard University, Brigham and Women’s Hospital, Boston, MA, 2016

Residency: Radiation Oncology at University of Washington, Seattle, WA, 2020

Selected Publications from a Total of 21

Schaub SK,* Cook MM,* Park SY, Hippe DS, Liao JJ, Apisarnthanarax S, Bhatia S, Nghiem PT, Tseng YD, Parvathaneni U. Adjuvant single fraction radiation therapy in Merkel cell carcinoma of the head and neck. Advances in Radiation Oncology. Accepted Jul 2020. doi: 10.1016/j.adro.2020.07.003. In Press. *Equal author contribution.

Schaub SK, Tseng YD, Chang EL, Sahgal A, Saigal R, Hofstetter CP, Foote M, Ko AL, Yuh W, Mossa-Basha M, Mayr NA, Lo SS. Strategies to mitigate toxicities from SBRT for spinal metastases. Neurosurgery. 2019 Jul 2. pii: nyz213. doi: 10.1093/neuros/nyz213. PubMed PMID: 31264703.

 

Hartvigson PE, Apisarnthanarax S, Schaub SK, Cohen S, Bernier G, Koh WJ, Kim EY. Radiotherapy dose escalation to non-resected clinically involved pelvic sidewall lymph nodes in locally advanced rectal cancer. Advances in Radiation Oncology. 2019 Apr 1;4(3):478-486. doi: 10.1016/j.adro.2019.03.007. eCollection 2019 Jul-Sep. PubMed PMID: 31360803.

Schaub SK, Ermoian RP, Wang CL, O’Malley RB, Kim EY, Shuman WP, Hendrickson K, Apisarnthanarax S. Bridging the Radiation Oncology and Diagnostic Radiology Communication Gap: A Survey to Determine Usefulness and Optimal Presentation of Radiotherapy Treatment Plans for Radiologists. Current Problems in Diagnostic Radiology. 2019 Feb;pii: S0363-0188(18)30310-4. doi:10.1067/j.cpradiol.2019.02.009. Epub 2019 Feb 21. PubMed PMID: 30885420.

Schaub SK, Apisarnthanarax S, Bowen SR. Response to Long et al RE: “Functional Liver Imaging and Dosimetry to Predict Hepatotoxicity Risk in Cirrhotic Patients With Primary Liver Cancer.” Int J Radiat Oncol Biol Phys. 2019 Apr 1;103(5):1285-1286. doi:10.1016/j.ijrobp.2018.12.014. Epub 2019 Mar 13. PMID: 30900567.

Schaub SK, Apisarnthanarax S, Price RG, Nyflot MJ, Chapman TR, Matesan M, Vesselle HJ, Bowen SR. Functional Liver Imaging and Dosimetry to Predict Hepatotoxicity Risk in Cirrhotic Patients With Primary Liver Cancer. Int J Radiat Oncol Biol Phys: Imaging Special Edition. 2018 Nov 15;102(4):1339-1348. doi: 10.1016/j.ijrobp.2018.08.029. Epub 2018 Aug 28. PubMed PMID: 30170100.

Price RG, Apisarnthanarax S, Schaub SK, Nyflot MJ, Chapman TR, Matesan M, Vesselle HJ, Bowen SR. Regional Radiation Dose-Response Modeling of Functional Liver in Hepatocellular Carcinoma Patients With Longitudinal Sulfur Colloid SPECT/CT: A Proof of Concept. Int J Radiat Oncol Biol Phys: Imaging Special Edition. 2018 Nov 15;102(4):1349-1356. doi: 10.1016/j.ijrobp.2018.06.017. Epub 2018 Jun 19. PubMed PMID: 29932945.

Schaub SK, Stewart RD, Sandison GA, Arbuckle T, Liao JJ, Laramore GE, Zeng J, Rengan R, Tseng YD, Mayr NA, Bhatia S, Nghiem PT, Parvathaneni U. Does Neutron Radiation Therapy Potentiate an Immune Response to Merkel Cell Carcinoma?. International Journal of Particle Therapy: Radiobiology Special Edition. 2018 Summer;5(1):183-195. doi: 10.14338/IJPT-18-00012.1. Epub 2018 Sep 21. PubMed PMID: 31773029.

Schaub SK, Hartvigson PE, Lock MI, Høyer M, Brunner TB, Cardenes HR, Dawson LA, Kim EY, Mayr NA, Lo SS, Apisarnthanarax S. Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current Trends and Controversies. Technol Cancer Res Treat. 2018 Jan 1;17:1533033818790217. doi: 10.1177/1533033818790217. PubMed PMID: 30068240.

Ahmed KA, Demetriou SK, McDonald M, Johnstone PA. Clinical Benefits of Proton Beam Therapy for Tumors of the Skull Base. Cancer Control. 2016 Jul;23(3):213-9. Review. PubMed PMID: 27556661.

Demetriou SK, Ona-Vu K, Sullivan EM, Dong TK, Hsu SW, Oh DH. Defective DNA repair and cell cycle arrest in cells expressing Merkel cell polyomavirus T antigen. Int J Cancer. 2012 Oct 15;131(8):1818-27. doi: 10.1002/ijc.27440. Epub 2012 May 29. PubMed PMID: 22261839.

 

Bibliography: https://www-ncbi-nlm-nih-gov.offcampus.lib.washington.edu/myncbi/collections/mybibliography/